Complicaciones cardiovasculares tempranas de pacientes con infarto agudo de miocardio con elevación del segmento ST en la Foscal entre 2013 y 2018. Estudio Comcardio-ST

dc.contributor.advisorVesga Angarita, Boris Eduardospa
dc.contributor.advisorOchoa Vera, Miguel Enriquespa
dc.contributor.authorRuiz Bedoya, Custodio Albertospa
dc.contributor.cvlachttps://scienti.minciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0000898465*
dc.contributor.cvlachttps://scienti.minciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0000020028*
dc.contributor.orcidhttps://orcid.org/0000-0001-6258-1195*
dc.contributor.orcidhttps://orcid.org/0000-0002-4552-3388*
dc.contributor.researchgatehttps://www.researchgate.net/profile/Boris_Vesga*
dc.contributor.researchgatehttps://www.researchgate.net/profile/Miguel_Ochoa7*
dc.contributor.scopushttps://www.scopus.com/authid/detail.uri?authorId=6507727347*
dc.contributor.scopushttps://www.scopus.com/authid/detail.uri?authorId=36987156500*
dc.coverageBucaramanga (Santander, Colombia)spa
dc.coverage.campusUNAB Campus Bucaramangaspa
dc.coverage.temporal2013-2016spa
dc.date.accessioned2020-06-26T19:59:51Z
dc.date.available2020-06-26T19:59:51Z
dc.date.issued2017
dc.degree.nameEspecialista en Medicina Internaspa
dc.description.abstractAntecedentes: El infarto agudo de miocardio con elevación del segmento ST es el escenario de mayor mortalidad aguda de la enfermedad cardiaca isquémica. Sin embargo en los últimos años, con el advenimiento de diferentes estrategias de reperfusión miocárdica temprana, su letalidad se ha visto reducida. Se desconocen las características epidemiológicas y clínicas de nuestros pacientes. Métodos: El estudio ComCardio-ST es un estudio de cohorte retrospectiva de los pacientes que ingresaron a la FOSCAL en los últimos tres años con diagnóstico de infarto con elevación del segmento ST. Se recolectaron datos del episodio de hospitalización con la intención de realizar una descripción de sus características epidemiológicas. A su vez se realizó un análisis de los factores asociados a mortalidad y complicaciones intrahospitalarias. Resultados: Se incluyeron 223 pacientes que cumplían con los criterios de inclusión. El promedio de edad fue de 64,75 años y en su mayoría fueron hombres (63,38%). La HTA fue el factor de riesgo más prevalente (63,23%) seguido por la dislipidemia (46,19%) y el tabaquismo (37,67%). El uso de medicamentos para las comorbilidades fue siempre menor al 35%. El compromiso electrocardiográfico más frecuente fue en la pared anterior (47,98%) seguida por la inferior (44,84%). La mayoría de los pacientes fueron catalogados con riesgo bajo de mortalidad según las diferentes escalas. La mortalidad general fue del 11,2% sin diferencias en cuanto a la terapia de reperfusión instaurada (6,6% en angioplastia primaria Vs 6,06% en terapia fármaco invasiva). La mayoría de los pacientes ingresaron a la institución en ventana de reperfusión (82%), pudiéndose realizar en el 77% de ellos, alguna estrategia de reperfusión. El cumplimiento de las metas de reperfusión fue bajo (27%) pero esto se asoció de manera significativa con un 88% menos de mortalidad que en el grupo de pacientes no reperfundidos. La incidencia de complicaciones clínicas derivadas del infarto fue del 41%, siendo la más frecuente de éstas el choque cardiogénico y la angina post IAM. Las complicaciones mecánicas se presentaron en el 63% de los pacientes, siendo la más frecuente la insuficiencia mitral moderada, aunque se desconoce la prevalencia de éste hallazgo al ingreso. Las complicaciones derivadas de las estrategias de reperfusión ocurrieron en el 30%, siendo la más frecuente el sangrado mayor , el cual se asoció con un riesgo tres veces mayor de mortalidad intrahospitalaria en el análisis bivariado. No obstante su efecto no fue significativo tras ajuste por covariables. El rendimiento de las escalas pronosticas GRACE y TIMMI-ST fue bueno con áreas bajo la curva de 0.856 y 0.836 respectivamente. Conclusiones: Se logró una caracterización de la población de pacientes con infarto agudo de miocardio con elevación del segmento ST. Se identificaron los factores de riesgo más prevalentes y un amplio potencial de intervención terapéutica en prevención primaria. Se documentó un alto porcentaje de realización de estrategias de reperfusión primaria y de terapia fármaco invasiva. Adicionalmente se objetivaron los tiempos en consulta, diagnóstico e instauración de terapias de reperfusión encontrándose un bajo cumplimiento de metas terapéuticas. Los resultados consolidan la base para iniciar un proceso cuantificable y trazable en el tiempo sobre la atención institucional del infarto.spa
dc.description.abstractenglishBackground: Acute ST-segment elevation myocardial infarction is the scene of the highest acute mortality in ischemic heart disease. However, in recent years, with the advent of different early myocardial reperfusion strategies, its lethality has been reduced. The epidemiological and clinical characteristics of our patients are unknown. Methods: The ComCardio-ST study is a retrospective cohort study of patients admitted to FOSCAL in the last three years with a diagnosis of ST-segment elevation infarction. Data on the hospitalization episode were collected with the intention of making a description of its epidemiological characteristics. In turn, an analysis of the factors associated with in-hospital mortality and complications was performed. Results: 223 patients who fulfilled the inclusion criteria were included. The average age was 64.75 years and the majority were men (63.38%). HT was the most prevalent risk factor (63.23%) followed by dyslipidemia (46.19%) and smoking (37.67%). The use of drugs for comorbidities was always less than 35%. The most frequent electrocardiographic involvement was in the anterior wall (47.98%) followed by the inferior wall (44.84%). Most of the patients were classified as having a low risk of mortality according to the different scales. Overall mortality was 11.2% with no differences regarding the reperfusion therapy instituted (6.6% in primary angioplasty vs. 6.06% in invasive drug therapy). Most of the patients were admitted to the institution in the reperfusion window (82%), and some reperfusion strategy could be carried out in 77% of them. The fulfillment of the reperfusion goals was low (27%) but this was significantly associated with 88% less mortality than in the group of non-reperfused patients. The incidence of clinical complications derived from infarction was 41%, the most frequent of these being cardiogenic shock and post-AMI angina. Mechanical complications occurred in 63% of the patients, the most frequent being moderate mitral regurgitation, although the prevalence of this finding on admission is unknown. Complications derived from reperfusion strategies occurred in 30%, the most frequent being major bleeding, which was associated with a three times higher risk of in-hospital mortality in the bivariate analysis. However, its effect was not significant after adjustment for covariates. The performance of the GRACE and TIMMI-ST forecast scales was good with areas under the curve of 0.856 and 0.836 respectively. Conclusions: A characterization of the population of patients with acute myocardial infarction with ST segment elevation was achieved. The most prevalent risk factors and a wide potential for therapeutic intervention in primary prevention were identified. A high percentage of performing primary reperfusion strategies and invasive drug therapy was documented. Additionally, the times in consultation, diagnosis and establishment of reperfusion therapies were observed, finding low compliance with therapeutic goals. The results consolidate the basis for initiating a quantifiable and time-traceable process on institutional care for heart attacks.eng
dc.description.degreelevelEspecializaciónspa
dc.description.learningmodalityModalidad Presencialspa
dc.description.tableofcontentsLISTADO DE TABLAS 8 LISTADO DE GRÁFICAS 10 RESUMEN Y PALABRAS CLAVE 11 INTRODUCCIÓN 13 1. OBJETIVOS 15 1.1. Objetivo General: 15 1.2. Objetivos Específicos: 15 2. PLANTEAMIENTO DEL PROBLEMA 17 3. MARCO TEÓRICO Y ESTADO DE ARTE 21 3.1. Epidemiología 21 3.2. Definiciones 23 3.3. Manifestaciones Clínicas del IAMCEST 26 3.4. Escalas de Riesgo en IAMCEST 27 3.5. Estrategias de reperfusión del IAMCEST 29 3.6. Manejo farmacológicos del IAMCEST 34 3.7. Complicaciones del IAMCEST 34 4. METODOLOGÍA 38 4.1. Diseño: 38 4.2. Tiempo de Estudio: 38 4.3. Población Blanco 38 4.4. Población de Referencia: 38 4.5. Población Elegible: 38 4.6. Población Incluida: 38 4.7. Criterios de Inclusión: 38 4.8. Criterios de exclusión: 38 4.9. Muestra: 39 4.10. Variables: 39 4.11. Recolección de la Información: 40 4.12. Procesamiento y control de calidad de los datos: 41 4.13. Análisis Estadístico Univariado: 41 4.14. Análisis Estadístico Bivariado: 41 4.15. Análisis Estadístico Multivariado: 42 5. CONSIDERACIONES ÉTICAS 42 6. RESULTADOS 43 6.1. Análisis Univariado 43 6.2. Análisis Bivariado 62 6.3. Análisis Multivariado 80 7. DISCUSIÓN. 84 8. LIMITACIONES 91 9. CONCLUSIONES 92 ANEXO 1. TABLA DE VARIABLES 94 ANEXO 2. FORMATO DE RECOLECCIÓN DE DATOS 109 ANEXO 4. ABREVIATURAS 112 REFERENCIAS BIBLIOGRÁFICAS 114spa
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga - UNABspa
dc.identifier.reponamereponame:Repositorio Institucional UNABspa
dc.identifier.urihttp://hdl.handle.net/20.500.12749/1727
dc.language.isospaspa
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNABspa
dc.publisher.programEspecialización en Medicina Internaspa
dc.relation.referencesRuiz Bedoya, Custodio Alberto (2017). Complicaciones cardiovasculares tempranas de pacientes con infarto agudo de miocardio con elevación del segmento ST en la Foscal entre 2013 y 2018. Estudio Comcardio-ST. Bucaramanga (Santander, Colombia) : Universidad Autónoma de Bucaramanga UNABspa
dc.relation.references1. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva, WHO, 2010.spa
dc.relation.references2. WHO. Fact sheet N310. Updated June 2011 (http://www.who.int/mediacentre/factsheets/fs310/en/index.html.)spa
dc.relation.references3. Instituto Nacional de Salud, Observatorio Nacional de Salud, Quinto Informe ONS: carga de enfermedad por enfermedades crónicas no transmisibles y discapacidad en Colombia. Imprenta Nacional de Colombia, Bogotá, D.C., 2015.spa
dc.relation.references4. Hernandez, M. (2016) Adherencia A La Guía De Práctica Clínica Para El Diagnóstico Y Tratamiento Del Síndrome Coronario Agudo En Adultos Que Consultan Al Servicio De Urgencias De La Fundación Oftalmológica De Santander – Clínica Carlos Ardila Lulle (AGUSCA). Tesis de grado de especialización en medicina interna. Universidad Autónoma de Bucaramanga. Colombia (Datos no publicados)spa
dc.relation.references5. Fox, K. A., Dabbous, O. H., Goldberg, R. J., Pieper, K. S., Eagle, K. A., Van de Werf, F., ... & Granger, C. B. (2006). Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ, 333(7578), 1091.spa
dc.relation.references6. García-Castillo, A., Jerjes-Sánchez, C., Martínez Bermúdez, P., Azpiri-López, J. R., Autrey Caballero, A., Martínez Sánchez, C., ... & Treviño, A. J. (2005). Registro Mexicano de Síndromes Coronarios Agudos: RENASICA II Mexican Registry of Acute Coronary Syndromes. Archivos de cardiología de México, 75, 6-19.spa
dc.relation.references7. Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., ... & Lisheng, L. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The lancet, 364(9438), 937-952.spa
dc.relation.references8. Kristensen, S. D., Laut, K. G., Fajadet, J., Kaifoszova, Z., Kala, P., Di Mario, C., ... & Alhabib, K. F. (2014). Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. European heart journal, eht 529.spa
dc.relation.references9. Martinez-Sanchez, C., Borrayo, G., Carrillo, J., Juarez, U., Quintanilla, J., & Jerjes-Sanchez, C. (2015). Clinical management and hospital outcomes of acute coronary syndrome patients in Mexico: The Third National Registry of Acute Coronary Syndromes (RENASICA III). Archivos de cardiologia de Mexico, 86(3), 221-232.spa
dc.relation.references10. Keeley, E. C., Boura, J. A., & Grines, C. L. (2003). Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. The Lancet, 361(9351), 13-20.spa
dc.relation.references11. American College of Emergency Physicians. (2013). 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 61(4), e78.spa
dc.relation.references12. American College of Emergency Physicians. (2013). 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 61(4), e78.spa
dc.relation.references13. Colombia. Ministerio de Salud y Protección Social, Colciencias, Universidad de Antioquia. Guía de referencia rápida. Guía para el Síndrome Coronario Agudo. GPC-SCA. Bogotá, 2013. GPC-2013-17.spa
dc.relation.references14. Al Shammeri, O., & Garcia, L. A. (2013). Thrombolysis in the age of Primary Percutaneous Coronary Intervention: Mini-Review and Meta-analysis of Early PCI. International journal of health sciences, 7(1), 91.spa
dc.relation.references15. Dharma, S., Juzar, D. A., Firdaus, I., Soerianata, S., Wardeh, A. J., & Jukema, J. W. (2012). Acute myocardial infarction system of care in the third world. Netherlands Heart Journal, 20(6), 254-259.spa
dc.relation.references16. Addad, F., Gouider, J., Boughzela, E., Kamoun, S., Boujenah, R., Haouala, H., ... & Baccar, H. (2015, December). Prise en charge de l’infarctus du myocarde en Tunisie: résultats préliminaires du registre FAST-MI Tunisie de la Société tunisienne de cardiologie et de chirurgie cardiovasculaire. In Annales de cardiologie et d'angeiologie (Vol. 64, No. 6, pp. 439-445). Elsevier Masson.spa
dc.relation.references17. Danchin, N., Puymirat, E., Steg, P. G., Goldstein, P., Schiele, F., Belle, L., ... & Ferrières, J. (2014). Five-year survival in patients with ST-segment elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 cohort. Circulation, CIRCULATIONAHA-113.spa
dc.relation.references18. Nallamothu, B. K., Bates, E. R., Herrin, J., Wang, Y., Bradley, E. H., & Krumholz, H. M. (2005). Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States. Circulation, 111(6), 761-767.spa
dc.relation.references19. Chavarriaga, J. C., Beltrán, J., Senior, J. M., Fernández, A., Rodríguez, A., & Toro, J. M. (2014). Características epidemiológicas, clínicas, tratamiento y pronóstico de los pacientes con diagnóstico de síndrome coronario agudo en unidad especializada. Acta Med Colomb, 39(1), 21-8.spa
dc.relation.references20. Cano, N. (2004). Epidemiologia del infarto agudo del miocardio en el hospital Santa Sofía de Manizales. Estudio descriptivo. Revista Colombiana de Cardiología, 11(3), 0120-5638.spa
dc.relation.references21. Sim, D. S., Jeong, M. H., Ahn, Y., Kim, Y. J., Chae, S. C., Hong, T. J., ... & Rha, S. W. (2016). Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment–Elevation Myocardial Infarction. Circulation: Cardiovascular Interventions, 9(9), e003508.spa
dc.relation.references22. Arriaga-Nava, R., Valencia-Sánchez, J. S., Rosas-Peralta, M., Garrido-Garduño, M., & Calderón-Abbo, M. (2015). Trombólisis prehospitalaria: en perspectiva nacional. Estrategia farmacoinvasiva para la reperfusión temprana del IAMCEST en México. Archivos de cardiología de México, 85(4), 307-317spa
dc.relation.references23. De la Cal, T. S., San Román, S. C., & Gómez, J. Z. (2013). Complicaciones del infarto de miocardio. Medidas terapéuticas. Medicine-Programa de Formación Médica Continuada Acreditado, 11(37), 2256-2262.spa
dc.relation.references24. Vesga, B. E., Beltrán J. R. (2015). Complicaciones del Infarto Agudo del miocardio. Manual de normas y procedimientos en Cardiología. Ed. Distribuna. Colombia.spa
dc.relation.references25. Vasquez, S. H. (2011). Registro de las Intervenciones Médicas del Síndrome Coronario Agudo manejado en el HUS. Tesis de grado para especialización en Medicina Interna. Universidad industrial de Santander. Bucaramanga. Colombia.spa
dc.relation.references26. World Health Organization. Cardiovascular Disease: Global Atlas on Cardiovascular Disease Prevention and Control, 2012. World Health Organization: Geneva.spa
dc.relation.references27. Laslett, L. J., Alagona, P., Clark, B. A., Drozda, J. P., Saldivar, F., Wilson, S. R., ... & Hart, M. (2012). The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. Journal of the American College of Cardiology, 60(25), S1-S49.spa
dc.relation.references28. Smith, S. C., Collins, A., Ferrari, R., Holmes, D. R., Logstrup, S., McGhie, D. V., ... & Wood, D. A. (2012). Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). European heart journal, 33(23), 2910-2916.spa
dc.relation.references29. Mendis, S., Puska, P., & Norrving, B. (2011). Global atlas on cardiovascular disease prevention and control. World Health Organization.spa
dc.relation.references30. Bloom, D., Cafiero, E., Jané-Llopis, E., Abrahams-Gessel, S., Bloom, L., Fathima, S., ... & O’Farrell, D. (2012). The global economic burden of noncommunicable diseases. Program on the Global Demography of Aging.spa
dc.relation.references31. Gaziano, T. A. (2007). Reducing the growing burden of cardiovascular disease in the developing world. Health affairs, 26(1), 13-24.spa
dc.relation.references32. Sénior JM LL, Acosta N, Acosta JL, Díaz J, Osío O, Plata JA, Saldarriaga CI. (2013) Guía de la práctica clínica para el Síndrome Coronario Agudo. Sistema General de Seguridad Social en Salud – Colombia. Colciencias.spa
dc.relation.references33. Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., ... & Kittner, S. (2007). Heart disease and stroke statistics—2007 update. Circulation, 115(5), e69-e1spa
dc.relation.references34. Widimsky, P., Wijns, W., Fajadet, J., De Belder, M., Knot, J., Aaberge, L., ... & Danchin, N. (2010). Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. European heart journal, 31(8), 943-957.spa
dc.relation.references35. Yeh, R. W., Sidney, S., Chandra, M., Sorel, M., Selby, J. V., & Go, A. S. (2010). Population trends in the incidence and outcomes of acute myocardial infarction. New England Journal of Medicine, 362(23), 2155-2165.spa
dc.relation.references36. Mandelzweig, L., Battler, A., Boyko, V., Bueno, H., Danchin, N., Filippatos, G., ... & Van de Werf, F. (2006). The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. European heart journal, 27(19), 2285-2293.spa
dc.relation.references37. Goldberg, R. J., Spencer, F. A., Fox, K. A., Brieger, D., Steg, P. G., Gurfinkel, E., ... & Gore, J. M. (2009). Prehospital delay in patients with acute coronary syndromes (from the Global Registry of Acute Coronary Events [GRACE]). The American journal of cardiology, 103(5), 598-603.spa
dc.relation.references38. Roe, M. T., Messenger, J. C., Weintraub, W. S., Cannon, C. P., Fonarow, G. C., Dai, D., ... & Hewitt, K. (2010). Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. Journal of the American College of Cardiology, 56(4), 254-263.spa
dc.relation.references39. Elliott, J., Wang, T. K. M., Gamble, G., Williams, M., Matsis, P., Troughton, R., ... & French, J. (2017). A decade of improvement in the management of New Zealand ST-elevation myocardial infarction (STEMI) patients: results from the New Zealand Acute Coronary Syndrome (ACS) Audit Group national audits of 2002, 2007 and 2012. The New Zealand medical journal, 130(1453), 17.spa
dc.relation.references40. Thygesen, K., Alpert, J. S., & White, H. D. (2007). Universal definition of myocardial infarction. Journal of the American College of Cardiology, 50(22), 2173-2195.spa
dc.relation.references41. Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., & White, H. D. (2012). Third universal definition of myocardial infarction. Circulation, CIR-0b013e31826e1058.spa
dc.relation.references42. Mauricio, D., & Boris, V. (2008). Electrocardiografía. Sociedad Colombiana de Cardiología Y Cirugía Cardiovascular,.spa
dc.relation.references43. Zimetbaum, P. J., & Josephson, M. E. (2003). Use of the electrocardiogram in acute myocardial infarction. New England Journal of Medicine, 348(10), 933-940.spa
dc.relation.references44. Braunwald, E., & Libby, P. (2009). Tratado de cardiología [de] Braunwald: texto de medicina cardiovascular.spa
dc.relation.references45. Wang, K., Asinger, R. W., & Marriott, H. J. (2003). ST-segment elevation in conditions other than acute myocardial infarction. New England Journal of Medicine, 349(22), 2128-2135.spa
dc.relation.references46. Lopes, R. D., Siha, H., Fu, Y., Mehta, R. H., Patel, M. R., Armstrong, P. W., & Granger, C. B. (2011). Diagnosing acute myocardial infarction in patients with left bundle branch block. The American journal of cardiology, 108(6), 782-788.spa
dc.relation.references47. Panju, A. A., Hemmelgarn, B. R., Guyatt, G. H., & Simel, D. L. (1998). Is this patient having a myocardial infarction?. Jama, 280(14), 1256-1263.spa
dc.relation.references48. Kannel, W. B., & Abbott, R. D. (1984). Incidence and prognosis of unrecognized myocardial infarction: an update on the Framingham study. New England Journal of Medicine, 311(18), 1144-1147.spa
dc.relation.references49. Mendoza, F., Isaza, D., Beltrán, R., Jaramillo, C., Beltrán, J., & Bohórquez, R. (2010). Guías Colombianas de Cardiología-Síndrome coronario agudo con elevación del ST. Rev Col Cardiol, 17(Supl 3), 121-275.spa
dc.relation.references50. Fox, K. A., Eagle, K. A., Gore, J. M., Steg, P. G., & Anderson, F. A. (2010). The global registry of acute coronary events, 1999 to 2009–GRACE. Heart, hrt-2009.spa
dc.relation.references51. Henrikson, C. A., Howell, E. E., Bush, D. E., Miles, J. S., Meininger, G. R., Friedlander, T., ... & Chandra-Strobos, N. (2003). Chest pain relief by nitroglycerin does not predict active coronary artery disease. Annals of internal medicine, 139(12), 979-986.spa
dc.relation.references52. Lee, Thomas H., et al. "Acute chest pain in the emergency room: identification and examination of low-risk patients." Archives of Internal Medicine 145.1 (1985): 65-69.spa
dc.relation.references53. Lee, K. L., Woodlief, L. H., Topol, E. J., Weaver, W. D., Betriu, A., Col, J., ... & Califf, R. M. (1995). Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Circulation, 91(6), 1659-1668.spa
dc.relation.references54. Killip, T., & Kimball, J. T. (1967). Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. The American journal of cardiology, 20(4), 457-464.spa
dc.relation.references55. DeGeare, V. S., Boura, J. A., Grines, L. L., O’Neill, W. W., & Grines, C. L. (2001). Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. The American journal of cardiology, 87(9), 1035-1038.spa
dc.relation.references56. Mello, B. H. G. D., Oliveira, G. B. F., Ramos, R. F., Lopes, B. B. C., Barros, C. B. S., Carvalho, E. D. O., ... & Piegas, L. S. (2014). Validation of the Killip-Kimball classification and late mortality after acute myocardial infarction. Arquivos brasileiros de cardiologia, 103(2), 107-117.spa
dc.relation.references57. Morrow, D. A., Antman, E. M., Charlesworth, A., Cairns, R., Murphy, S. A., de Lemos, J. A., ... & Braunwald, E. (2000). TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. Circulation, 102(17), 2031-2037.spa
dc.relation.references58. Fox, K. A., Anderson, F. A., Dabbous, O. H., Steg, P. G., López-Sendón, J., Van de Werf, F., ... & Brieger, D. (2007). Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart, 93(2), 177-182.spa
dc.relation.references59. Sénior, J. M., Fernández, A., Rodríguez, A., Muñoz, E., Díaz, J., Gándara, J., ... & Jaimes, F. (2016). Validación y comparación de los puntajes TIMI y GRACE en pacientes con síndrome coronario agudo sin elevación del segmento ST. Revista Colombiana de Cardiología, 23(6), 479-486.spa
dc.relation.references60. Luepker, R. V., Raczynski, J. M., Osganian, S., Goldberg, R. J., Finnegan Jr, J. R., Hedges, J. R., ... & Labarthe, D. R. (2000). Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial. Jama, 284(1), 60-67.spa
dc.relation.references61. Steg, P. G., Cambou, J. P., Goldstein, P., Durand, E., Sauval, P., Kadri, Z., ... & Juliard, J. M. (2006). Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry. Heart, 92(10), 1378-1383.spa
dc.relation.references62. Asseburg, C., Vergel, Y. B., Palmer, S., Fenwick, E., de Belder, M., Abrams, K. R., & Sculpher, M. (2007). Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis. Heart, 93(10), 1244-1250.spa
dc.relation.references63. Trialists, F. T. (1994). Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. The lancet, 343(8893), 311-322.spa
dc.relation.references64. Berger, A. K. (2003). Thrombolysis in elderly patients with acute myocardial infarction. The American journal of geriatric cardiology, 12(4), 251-258.spa
dc.relation.references65. Zhang, B. C., Zhou, Z. W., Hou, L., Zhang, J., Li, W. M., & Xu, Y. W. (2011). A meta-analysis of early percutaneous coronary intervention within 24 hours of thrombolysis in acute ST-elevation myocardial infarction.spa
dc.relation.references66. Sim, D. S., Jeong, M. H., Ahn, Y., Kim, Y. J., Chae, S. C., Hong, T. J., ... & Rha, S. W. (2016). Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment–Elevation Myocardial Infarction. Circulation: Cardiovascular Interventions, 9(9), e003508.spa
dc.relation.references67. Sinnaeve, P. R., Danays, T., Bogaerts, K., Van de Werf, F., & Armstrong, P. W. (2016). Drug treatment of STEMI in the elderly: Focus on fibrinolytic therapy and insights from the STREAM trial. Drugs & aging, 33(2), 109-118.spa
dc.relation.references68. Van de Werf, F., Barron, H. V., Armstrong, P. W., Granger, C. B., Berioli, S., Barbash, G., ... & Califf, R. M. (2001). Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents. A comparison of TNK-tPA and rt-PA. European heart journal, 22(24), 2253-2261.spa
dc.relation.references69. Van de Werf, F. (1999). Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. The Lancet, 354(9180), 716-722.spa
dc.relation.references70. Comité científico FOSCAL. Guías de manejo del Infarto Agudo del Miocardio con Elevación del Segmento ST o Bloqueo Completo de Rama Izquierda. 2016.spa
dc.relation.references71. Subherwal, S., Bach, R. G., Chen, A. Y., Gage, B. F., Rao, S. V., Newby, L. K., ... & Pollack, C. V. (2009). Baseline risk of major bleeding in non–ST-segment–elevation myocardial infarction. Circulation, 119(14), 1873-1882.spa
dc.relation.references72. Goldberg, R. J., Spencer, F. A., Gore, J. M., Lessard, D., & Yarzebski, J. (2009). Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction. Circulation, 119(9), 1211-1219.spa
dc.relation.references73. Menon, V., White, H., LeJemtel, T., Webb, J. G., Sleeper, L. A., Hochman, J. S., & SHOCK Investigators. (2000). The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. Journal of the American College of Cardiology, 36(3), 1071-1076.spa
dc.relation.references74. Jeger, R. V., Lowe, A. M., Buller, C. E., Pfisterer, M. E., Dzavik, V., Webb, J. G., ... & Jorde, U. P. (2007). Hemodynamic parameters are prognostically important in cardiogenic shock but similar following early revascularization or initial medical stabilization: a report from the SHOCK Trial. CHEST Journal, 132(6), 1794-1803.spa
dc.relation.references75. Thomsen, P. E. B., Jons, C., Raatikainen, M. P., Joergensen, R. M., Hartikainen, J., Virtanen, V., ... & Boersma, L. V. (2010). Long-Term Recording of Cardiac Arrhythmias With an Implantable Cardiac Monitor in Patients With Reduced Ejection Fraction After Acute Myocardial InfarctionClinical Perspective. Circulation, 122(13), 1258-1264.spa
dc.relation.references76. Schmitt, J., Duray, G., Gersh, B. J., & Hohnloser, S. H. (2008). Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. European heart journal.spa
dc.relation.references77. Brugada, J., Aguinaga, L., Mont, L., Betriu, A., Mulet, J., & Sanz, G. (2001). Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome. Journal of the American College of Cardiology, 37(2), 529-533.spa
dc.relation.references78. Vardas, P. E., Auricchio, A., Blanc, J. J., Daubert, J. C., Drexler, H., Ector, H., ... & Sutton, R. (2007). Guidelines for cardiac pacing and cardiac resynchronization therapy. Europace, 9(10), 959-998.spa
dc.relation.references79. De Luca, G., Suryapranata, H., van’t Hof, A. W., de Boer, M. J., Hoorntje, J. C., Dambrink, J. H. E., ... & Zijlstra, F. (2004). Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty. Circulation, 109(22), 2737-2743.spa
dc.relation.references80. Chevalier, P., Burri, H., Fahrat, F., Cucherat, M., Jegaden, O., Obadia, J. F., ... & Touboul, P. (2004). Perioperative outcome and long-term survival of surgery for acute post-infarction mitral regurgitation. European journal of cardio-thoracic surgery, 26(2), 330-335.spa
dc.relation.references81. Lemery, R., Smith, H. C., Giuliani, E. R., & Gersh, B. J. (1992). Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention. The American journal of cardiology, 70(2), 147-151.spa
dc.relation.references82. Imazio, M., Negro, A., Belli, R., Beqaraj, F., Forno, D., Giammaria, M., ... & Spodick, D. (2009). Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention. The American journal of cardiology, 103(11), 1525-1529.spa
dc.relation.references83. Maisch, B., Seferović, P. M., Ristić, A. D., Erbel, R., Rienmüller, R., Adler, Y., ... & Garcia, M. A. A. (2004). Guidelines on the diagnosis and management of pericardial diseases executive summary. European heart journal, 25(7), 587-610.spa
dc.relation.references84. Turpie, A. G., Robinson, J. G., Doyle, D. J., Mulji, A. S., Mishkel, G. J., Sealey, B. J., ... & Gent, M. (1989). Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. New England Journal of Medicine, 320(6), 352-357.spa
dc.relation.references85. Grace Investigators. (2001). Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. American heart journal, 141(2), 190-199.spa
dc.relation.references86. Isaza, V. D., & Plata, E. (2012). ACCES: En cuesta de estrategia de manejo en síndrome coronario agudo (SCA). Resultados de los 12 meses de seguimiento en la poa blación de Colombia comparada con Latinoamérica. Rev Col Cardiol, 35.spa
dc.relation.references87. Coronado, B. E., Griffith, J. L., Beshansky, J. R., & Selker, H. P. (1997). Hospital mortality in women and men with acute cardiac ischemia: a prospective multicenter study. Journal of the American College of Cardiology, 29(7), 1490-1496spa
dc.relation.references88. Gharacholou, S. M., Alexander, K. P., Chen, A. Y., Wang, T. Y., Melloni, C., Gibler, W. B., ... & Roe, M. T. (2010). Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRUSADE initiative. American heart journal, 159(5), 757-763.spa
dc.relation.references89. Juárez‐Herrera, Úrsulo, and Carlos Jerjes‐Sánchez. "Risk Factors, Therapeutic Approaches, and In‐Hospital Outcomes in Mexicans With ST‐Elevation Acute Myocardial Infarction: The RENASICA II Multicenter Registry." Clinical cardiology 36.5 (2013): 241-248.spa
dc.relation.references90. Schargrodsky, H., Hernández-Hernández, R., Champagne, B. M., Silva, H., Vinueza, R., Ayçaguer, L. C. S., ... & Macchia, A. (2008). CARMELA: assessment of cardiovascular risk in seven Latin American cities. The American journal of medicine, 121(1), 58-65.spa
dc.relation.references91. Lanas, F., Avezum, A., Bautista, L. E., Diaz, R., Luna, M., Islam, S., & Yusuf, S. (2007). Risk factors for acute myocardial infarction in Latin America. Circulation, 115(9), 1067-1074.spa
dc.relation.references92. Gómez, L. F., Mateus, J. C., & Cabrera, G. (2004). Leisure-time physical activity among women in a neighbourhood in Bogotá, Colombia: prevalence and socio-demographic correlates. Cadernos de Saúde Pública, 20(4), 1103-1109.spa
dc.relation.references93. Go, A. S., Barron, H. V., Rundle, A. C., Ornato, J. P., & Avins, A. L. (1998). Bundle-branch block and in-hospital mortality in acute myocardial infarction. Annals of internal medicine, 129(9), 690-697.spa
dc.relation.references94. Gomez-Arbelaez, D., Sánchez-Vallejo, G., Perez, M., Garcia, R. G., Arguello, J. F., Peñaherrera, E., ... & Camacho, P. A. (2016). Hiperglucemia se asocia a mayor número de desenlaces adversos en individuos latinoamericanos con infarto agudo de miocardio. Clínica e Investigación en Arteriosclerosis, 28(1), 9-18.spa
dc.relation.references95. Cabrerizo-García, J. L., Gimeno-Orna, J. A., Zalba-Etayo, B., & Pérez-Calvo, J. I. (2011). La hiperglucemia como factor de mal pronóstico en el síndrome coronario agudo. Revista Clínica Española, 211(6), 275-282.spa
dc.relation.references96. Dharma, S., Andriantoro, H., Purnawan, I., Dakota, I., Basalamah, F., Hartono, B., ... & Pratama, V. (2016). Characteristics, treatment and in-hospital outcomes of patients with STEMI in a metropolitan area of a developing country: an initial report of the extended Jakarta Acute Coronary Syndrome registry. BMJ open, 6(8), e012193.spa
dc.relation.references97. Hernández-García, J., Giménez-Ruiz, J. J., & Dueñas-Jurado, J. M. (2016). Evaluación de resultados tras la implantación de un protocolo de fibrinólisis extra hospitalaria en zonas rurales. SEMERGEN-Medicina de Familia, 42(7), 440-448.spa
dc.relation.references98. Spencer, F. A., Moscucci, M., Granger, C. B., Gore, J. M., Goldberg, R. J., Steg, P. G., ... & Fox, K. A. (2007). Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?. Circulation, 116(24), 2793-2801.spa
dc.relation.references99. Diaz, J. J. S., Fernández, J. J. D., Montero, V. C. F., Posso, L. P. U., & Cortés, C. A. A. (2014). Descripción Clínica Y Tratamiento De Los Pacientes Con Síndrome Coronario Agudo En El Hospital San José De Bogotá. Acta Médica Colombiana, 39(2), 124-130.spa
dc.relation.references100. Sprockel, J. J., Diaztagle, J. J., Chaves, W. G., Heras, J. C., Simón, C. J., Afanador, D. C., ... & Hernández, J. I. (2015). Calidad de la atención de los síndromes coronarios agudos: implementación de una ruta crítica. Revista Colombiana de Cardiología, 22(3), 119-126.spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.rights.localAbierto (Texto Completo)spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.subject.keywordsMyocardial infarctioneng
dc.subject.keywordsCardiovascular complicationseng
dc.subject.keywordsReperfusioneng
dc.subject.keywordsMedicineeng
dc.subject.keywordsInternal medicineeng
dc.subject.keywordsInvestigationseng
dc.subject.keywordsComplicationseng
dc.subject.keywordsPatientseng
dc.subject.keywordsPrevention and controleng
dc.subject.keywordsAcute ST-segment elevation myocardial infarctioneng
dc.subject.keywordsPrimary angioplastyeng
dc.subject.keywordsThrombolysiseng
dc.subject.keywordsInvasive drug therapyeng
dc.subject.keywordsEarly cardiovascular complicationseng
dc.subject.lembInfarto del miocardiospa
dc.subject.lembComplicaciones cardiovascularesspa
dc.subject.lembReperfusiónspa
dc.subject.lembMedicinaspa
dc.subject.lembMedicina internaspa
dc.subject.lembInvestigacionesspa
dc.subject.lembComplicacionesspa
dc.subject.lembPacientesspa
dc.subject.lembPrevención y controlspa
dc.subject.proposalInfarto agudo de miocardio con elevación del segmento ST
dc.subject.proposalAngioplastia primaria
dc.subject.proposalTrombolisis
dc.subject.proposalTerapia fármaco invasiva
dc.subject.proposalComplicaciones cardiovasculares tempranas
dc.titleComplicaciones cardiovasculares tempranas de pacientes con infarto agudo de miocardio con elevación del segmento ST en la Foscal entre 2013 y 2018. Estudio Comcardio-STspa
dc.title.translatedEarly cardiovascular complications of patients with acute myocardial infarction with ST-segment elevation in the Foscal between 2013 and 2018. Comcardio-ST studyeng
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcc
dc.type.driverinfo:eu-repo/semantics/masterThesis
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.type.localTesisspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TM

Archivos

Bloque original

Mostrando 1 - 2 de 2
Cargando...
Miniatura
Nombre:
2017_Tesis_Custodio_Alberto_Ruiz_Bedoya.pdf
Tamaño:
1.94 MB
Formato:
Adobe Portable Document Format
Descripción:
Tesis
Cargando...
Miniatura
Nombre:
2017_Licencia_Custodio_Alberto_Ruiz_Bedoya.pdf
Tamaño:
118.85 KB
Formato:
Adobe Portable Document Format
Descripción:
Licencia